Little Mountain Homeopathy Client Testimonial
After 60 years of suffering with allergies and asthma, I have relief. Over the years I have taken various antihistamines with limited, unreliable results. Recently I decided to try homeopathic medicine with practitioner Sonya McLeod. First she recorded a thorough medical history, then prescribed a homeopathic remedy. During the cottonwood season, my nose dripped, I sneezed, coughed, and my throat and ears itched. I took the remedy and had immediate relief. Now I take a remedy as needed, to maintain and healthy respiratory system.
I found Sonya to be a professional, empathetic and effective homeopathic practitioner. I highly recommend her to anyone seeking a homeopathic practitioner.
Sincerely,
Diane Smith
Burnaby, BC
Hayfever
Seasonal Allergies
Food Allergies
Milk Allergies
Cat and Dog Allergies
Chemical Sensitivities
Metal Allergies
Skin Allergies
Eczema and Psoriasis
Skin Rash
Hives and Dermatitis
Read my own story published in babyvibe of how I was cured of debilitating fatigue and severe allergic symptoms with homeopathy – Homeopathy: My Cure for Allergies
When treating allergies with classical homeopathy, testing is not necessary, though it may be a useful tool as part of your healing journey. Classical homeopathic treatment desensitizes the body so that the body is strong enough to tolerate the allergen. Our medicines get to the root of the problem instead of merely telling you to limit your exposure to the allergen, so that you can lead a healthy normal life.
Numerous Studies Prove the Effectiveness of Homeopathy for all Kinds of Allergies
A review of homeopathic research in the treatment of respiratory allergies
Abstract
There are conceptual and historical links between homeopathic medicine and modern allergy desensitization treatment. Conventional allergy desensitization and homeopathic treatment both utilize small doses of substances that might cause symptoms in order to prevent or treat a hypersensitive state. Homeopathy has historically been associated with allergy treatment. This article reviews evidence from controlled trials for the use of homeopathy in respiratory allergies. Several clinical trials, many of which were published in “high impact” conventional medical journals, describe significant effects of homeopathic treatment in allergic patients. Most of these clinical studies have been deemed to be high quality trials, according to the three most commonly referenced meta-analyses of homeopathic research. Basic in vitro experimental studies also provide evidence that the effects of homeopathy differ from placebo.
The research evidence base for homeopathy: a fresh assessment of the literature
A systematic review of results from 93 substantive RCTs was carried out by Robert Mathie (2003). It concludes that of the 35 different medical conditions covered by these trials the weight of evidence favours a positive treatment effect in 8: childhood diarrhoea, fibrositosis, hay fever, influenza, pain (miscellaneous), side-effects of chemotherapy or radiotherapy, sprains and upper-respiratory tract infections.
Richardson J. “Quasi-randomised control trial to assess the outcome of acupuncture, osteopathy and homoeopathy using the short form 36 item health survey.” Health Services Research and Evaluation Unit, The Lewisham Hospital NHS Trust. December 1996.
The effect of homeopathy, acupuncture and osteopathy. Result: 89% of patients stated they experienced positive effect from the treatment. Particularly clear effect on reduction of pain, increased vitality, ability to function socially and with regards to limitations at work and in daily activities influenced by physical problems. Homeopathy was particularly effective for patients suffering from arthritis, hay fever, asthma and skin complaints.
Abstract
Many people are suffering from different kinds of allergies. The paper describes allergy desensitization
techniques based on the allergen dynamization method. Dynamization is used in homeopathy for
remedy preparation. The method involves repeated dilution and succussion of water with substances
containing allergens. Several cases of insect bites, pets, indoor and outdoor air-born, and food allergies
are reported. The described method is simple, yet effective for curing allergies of different origins.
In this study, 13 Dutch medical practitioners submitted patients (who between them had a mean history of hayfever of 9 years), for therapy involving injections of a combination homeopathic product. All but 1 patient were given the medication before the onset of the hayfever season and all were given it during the hayfever season. Of these 13, during the course of the trial 9 people found no increase in nasal and non-nasal hayfever symptoms when the hayfever season began or during it and only 1 of the 13 felt compelled to use conventional hayfever medication.
In this case series, 147 consecutive patients suffering from respiratory allergy who attended a private homeopathic clinic were assessed for their response to constitutional homeopathic treatment. Of these patients, 105 were sufferers of ear, nose and throat allergies. Only 2 of these patients failed to respond to treatment and none experienced an exacerbation of symptoms. The other 42 patients were sufferers of pulmonary allergies, all except 5 of whom experienced relief, with 2 of these experiencing an exacerbation of symptoms.
The Centre for Integrated Medicine in Pitigliano, Tuscany, is an innovative hospital providing homeopathy and acupuncture alongside conventional medical care. This article reports the results of an integrated homeopathic protocol used to treat 430 out-patients with seasonal and perennial respiratory allergies (e.g. rhinitis, oculorhinitis and asthma) from 2011-2014. Effectiveness was evaluated through the Quality of Life SF12 questionnaire, the Edmonton symptom assessment scale, change in consumption of conventional drugs and drop-out rates. When taken together, the results demonstrate that patients with respiratory allergies improve clinically following treatment with this integrated homeopathic protocol.
In a study carried out at the Technicon-Israel Institute in Haifa, Israel, 48 patients were treated for allergic disorders with both homoeopathic and conventional medicines, and monitored for their level of use of the conventional medicines. Over the 3 month monitoring period, 56% of patients reduced their conventional medication use by an average of 60%.
In this double-blind trial, 34 people diagnosed with moderate to severe seasonal allergic rhinitis were randomly assigned to receive either placebo or a combination of potentised allergens (made from the pollens of trees, grasses or weeds identified as allergens). After the 4 week treatment period using 2 sprays 3 times a day of either the potentised allergen mix or placebo, the trial subjects were assessed on the basis of their allergy specific symptoms using 3 separate questionnaire formats (RQLQ, MOS SF-36 and the WPAI). The potentised allergen mix showed significant positive changes compared to placebo.
This study reports the results of orthodox medical treatment compared to the homeopathic treatment of various hypersensitivity illnesses in 88 people. 34 of these people were treated using orthodox medical means and 54 using constitutional homeopathy. 24% of those treated medically experienced an improvement in their condition while 57% of those treated with homeopathy experienced similar relief.
Ludke R, Weisenauer M. “A Meta-analysis of Homeopathic Treatment of Pollinosis with Galphimia glauca.” Wiener Medizinische Wochenschrift, 1997, 147, 14, 323-7.
In this analysis, 7 randomised double-blind placebo controlled trials and 4 trials without placebo controls were examined to determine the therapeutic benefits of Galphimia glauca in pollinosis. In all studies except for one, Galphimia showed significant benefit over placebo where placebo controls were used, or showed significant clinical benefit where the remedy was not compared to placebo. The recovery rates for Galphimia were comparable with those seen with conventional anti-histamines, but without the same side effects.
Abstract
The hypothesis that homoeopathic potencies are placebos was tested in a randomised, double-blind, placebo-controlled trial. The study model chosen compared the effects of a homoeopathic preparation of mixed grass pollens with placebo in 144 patients with active hayfever. The homoeopathically treated patients showed a significant reduction in patient and doctor assessed symptom scores. The significance of this response was increased when results were corrected for pollen count and the response was associated with a halving of the need for antihistamines. An initial aggravation of symptoms was noted more often in patients receiving the potency and was followed by an improvement in that group. No evidence emerged to support the idea that placebo action fully explains the clinical responses to homoeopathic drugs.
Abstract
Objective: To test the hypothesis that homoeopathy is a placebo by examining its effect in patients with allergic rhinitis and so contest the evidence from three previous trials in this series.
Design: Randomised, double blind, placebo controlled, parallel group, multicentre study.
Setting: Four general practices and a hospital ear, nose, and throat outpatient department.
Participants: 51 patients with perennial allergic rhinitis.
Intervention: Random assignment to an oral 30c homoeopathic preparation of principal inhalant allergen or to placebo.
Main outcome measures: Changes from baseline in nasal inspiratory peak flow and symptom visual analogue scale score over third and fourth weeks after randomisation.
Results: Fifty patients completed the study. The homoeopathy group had a significant objective improvement in nasal airflow compared with the placebo group (mean difference 19.8 l/min, 95% confidence interval 10.4 to 29.1, P=0.0001). Both groups reported improvement in symptoms, with patients taking homoeopathy reporting more improvement in all but one of the centres, which had more patients with aggravations. On average no significant difference between the groups was seen on visual analogue scale scores. Initial aggravations of rhinitis symptoms were more common with homoeopathy than placebo (7 (30%) v 2 (7%), P=0.04). Addition of these results to those of three previous trials (n=253) showed a mean symptom reduction on visual analogue scores of 28% (10.9 mm) for homoeopathy compared with 3% (1.1 mm) for placebo (95% confidence interval 4.2 to 15.4, P=0.0007).
Conclusion: The objective results reinforce earlier evidence that homoeopathic dilutions differ from placebo.
In this trial, 146 people suffering from hay fever were treated with either Luffa comp.-Heel Nasal Spray (a homoeopathic combination product) or with Cromolyn Sodium Spray (a pharmaceutical drug commonly prescribed for hay fever). The treatment outcomes were measured according to a quality of life scale and both medicines provided the same level of remission of the condition, which was rapid and persistent.
Using a randomised, placebo-controlled, double-blind, multi-centre design in this trial, 86 people suffering from hay fever were treated for 5 and a half weeks with either homeopathic Galphimia glauca 4X or placebo. Therapeutic success was seen in 83% of those using the Galphimia and 47% of those using placebo.
54 practitioners treated 201 people suffering from hay fever either with placebo or homeopathic Galphimia glauca. Assessment at the end of the 5 week treatment period found that nasal symptoms were cured or significantly improved in 77% of subjects using Galphimia versus 46% of those using placebo and eye symptoms were cured or significantly improved in 77% of subjects using Galphimia versus 51% of those using placebo.
Abstract
Objective: 1) To assess the efficacy of homeopathically prepared Galphimia glaucacompared with placebo in the treatment of pollinosis; 2) to estimate the corresponding overall success rate of Galphimia glauca.
Design: Meta-analysis of clinical trials. Study Selection: Seven randomized double-blind placebo-controlled trials and 4 non-placebo-controlled trials (1 randomized and controlled, 1 prospective and uncontrolled) performed by our study group between 1980 and 1989. An additonal MEDLINE search revealed no further trials on this topic. Exclusion and inclusion criteria were identical over all trials. In total, 1,038 ambulatory patients who suffered from acute pollinosis (752 in placebo-controlled trials) entered the analysis.
Main Outcome Measures: Relative frequency and relative change for showing noticeable and soothing relief in ocular symptoms as assessed by the patient.
Results: The overall rate of improved eye symptoms is about 1.25 [confidence interval (CI): 1.09–1.43] times higher in the verum group than in the placebo group. Verum success rate is estimated by 79.3% (CI: 74.1–85.0%). Across the single studies the results were highly comparable except for the study run in 1985.
Conclusions: A significant superiority of Galphimia glauca over placebo is demonstrated. Estimates of verum success rates are comparable with those of conventional antihistaminics, but no side effects occurred. The results may be slightly biased since not all of the single studies were analyzed by intention-to-treat analysis.
Abstract
OBJECTIVES: To evaluate the effectiveness of homoeopathy versus conventional treatment in routine care.
DESIGN: Comparative cohort study.
SETTING: Patients with selected chronic diagnoses were enrolled in medical practice.
INTERVENTIONS: Conventional treatment or homeopathy.
OUTCOME MEASURES: Severity of symptoms assessed by patients and physicians (visual rating scale, 0-10) at baseline, 6 and 12 months and costs.
RESULTS: The analyses of 493 patients (315 adults, 178 children) indicated greater improvement in patients’ assessments after homoeopathic versus conventional treatment (adults: homeopathy from 5.7 to 3.2; conventional, 5.9-4.4; p=0.002; children from 5.1 to 2.6 and from 4.5 to 3.2). Physician assessments were also more favourable for children who had received homoeopathic treatment (4.6-2.0 and 3.9-2.7; p<0.001). Overall costs showed no significant differences between both treatment groups (adults, 2155 versus 2013, p=0.856; children, 1471 versus 786, p=0.137).
CONCLUSION: Patients seeking homoeopathic treatment had a better outcome overall compared with patients on conventional treatment, whereas total costs in both groups were similar.
In this controversial, blinded multi-centre trial (which confirmed earlier studies published in Nature in 1988), homeopathic potencies of histamine were found to substantially reduce the potential for degranulation by sensitised basophils when exposed to allergens.
In this study, which was a replication of work by Jacques Benveniste published in Nature in 1988, the researchers attempted to use homeopathic dilutions of histamine to inhibit the activation of human basophils exposed to an inflammatory mediator. The study was carried out blind in 4 separate laboratories. Histamine dilutions equivalent to 30X and 38X were found to inhibit basophil activation and subsequent histamine release.
Chirila M, Hristescu S, Manda G, Neagu M, Olinescu A. “The Action of Succussed Substances on the Human Lymphocytes and PMN Granulocytes in Vitro Stimulated with Phytohaemagglutinin (PHA) and Zymosin Opsonised (ZO).” Berlin Journal on Research in Homoeopathy, Congress Report, 1991, June, 1, 3, 166-167.
Peripheral blood lymphocytes were taken from people with a history of allergy to bee products (Group 1), and from people who were immunosuppressed (Group 2). These cells were incubated in culture media supplemented with a succussed water control, various homoeopathic potencies of bee venom (for Group 1 cells), or cortisone (for Group 2 cells), and the cells were grown. The proliferation of Group 1 cells was inhibited by the potencies of bee venom, indicating that these remedies may be useful in the management of allergies to bee products. The effects of the potencies of cortisone on the Group 2 cells varied from stimulation to inhibition.
Abstract
1. The effect of high dilutions of two homeopathic drugs Lung histamine (Lung his) and Apis mellifica (Apis mel) used for the treatment of allergic diseases has been assessed on in vitro human basophil degranulation. Experiments were conducted blind. 2. Basophil degranulation induced by 1.66 X 10(-9) M anti-IgE antibody was significantly inhibited in the presence of 5 Lung his (5th centesimal dilution of Lung his) and 15 Lung his (15th centesimal dilution of Lung his) by 28.8% and 28.6% respectively and by 65.8% in the presence of 9 Apis mel (9th centesimal dilution of Apis mel). Basophil degranulation induced by 1.66 X 10(-16) to 1.66 X 10(-18) M anti-IgE antibody was also inhibited by high dilutions of Lung his and Apis mel with an inhibition of nearly 100% with 18 Lung his (18th centesimal dilution of Lung his) and 10 Apis mel (10th centesimal dilution of Apis mel). An alternance of inhibition, inactivity and stimulation was observed when basophils were incubated in the presence of serial dilutions of Lung his and Apis mel. 3. The investigation of the clinical efficacy of high dilutions of Lung his and Apis mel should be envisaged in allergic diseases in parallel with in vitro and ex vivo biological assays.